Direct removal of endotracheal tube
ProcedurePatient will have direct removal of ETT and transferred to PACU breathing independently or with a face mask.
NCT Number: NCT07204990
During surgery, anaesthetists can use an endotracheal tube (ETT) to facilitate ventilation. At emergence from general anaesthesia, there are two techniques for removal of the ETT: (1) the ETT is removed when the child is waking up in (awake removal); or (2) the ETT is removed while still under anaesthesia(deep removal).
Currently there is no evidence to suggest either technique is safer - deep removal of the ETT may decrease the risk of overall airway complications, including cough and desaturations. However, it may be associated with increased airway obstruction compared with awake extubation in paediatric patients. In our institution, a further technique has become increasingly common practice: removing ETT deep to avoid coughing and desaturation, then inserting a laryngeal mask airway (LMA) which can be removed once the patient is awake in the postoperative care unit (PACU), avoiding the risk of airway obstruction coupled with deep airway removal. The aim of the study is to assess whether deep removal of an ETT and exchange to an LMA, is superior to awake ETT removal with regards to the occurrence of postoperative respiratory adverse events.
In this study, patients will be randomised to awake removal of ETT or deep removal of an ETT and exchange to an LMA. Data will be collected regarding the rate of respiratory adverse events in either group, as well as the incidence of post-operative pain, delirium and nausea and vomiting.
Interested in participating?
Request Info0 year–16 year
All sexes
Interventional
Not applicable
Perth Children's Hospital, Nedlands, Western Australia, Australia
Anaesthesia induction and maintenance will be performed as deemed appropriate by the attending anaesthetist. The choice and dose of analgesia will be at the discretion of the individual anaesthetist adjusted to the individual patient's needs. All clinical care will be in accordance with institutional standards.
All children undergoing surgery under general anaesthesia involving insertion of an endotracheal tube who arrive in the PCH post-anaesthetic care unit (PACU) between 0800 and 1800 on weekdays during the data collection periods will be included in this study under a waiver of consent. Surgical lists in our institution operate on four-week cycles (weeks A, B, C and D), with some surgical specialities scheduled for one list a fortnight or one list every four weeks and others having multiple lists per week. In order to ensure that both intervention groups have equal representation of each of the weeks A, B C and D, data collection will take place in 8-week blocks until such a time as the sample size has been reached.
Group ETT awake: ETT removal once the patient is fully awake (at least 3 of the following criteria: spontaneous tidal volume >5ml/kg, conjugate gaze, facial grimace, eye-opening, purposeful movement Group LMA exchange: ETT removal deep; @ at least 1 Mac or an equivalent depth of anaesthesia (if available BIS <60, Sedline <50), an additional bolus of propofol (1mg/kg) maybe given if deemed appropriate/ required prior to the ETT removal as per normal clinical practice. Following gentle suctioning around the ETT at the end of the case, the ETT is removed under deep anaesthesia and a LMA is inserted in its place.
There is no individual randomisation or blinding in this study. Extubation procedure (either ETT removed awake or ETT removed deep and exchanged for LMA) will each be used for 4 out of 8 weeks during the data collection period. The intervention assigned for the first 4-week cycle of the data collection period will be decided by the toss of a coin. Thereafter, intervention 1 (either ETT awake or LMA exchange) will be in place for weeks 4 weeks, with the alternate intervention in place for the subsequent 4 weeks. Given the nature of the intervention it is not possible to have blinding for this study. The statistical analysis will be performed by individuals blinded to the randomisation. This will be repeated until the required sample size has been reached
Demographic information routinely collected as part of normal clinical care will be recorded on a patient data sheet, including their date of birth, natal sex, height, weight, ethnicity and age on the day of surgery. Details about their condition on the day of surgery will be collected, including their American Society of Anaesthesiologists physical status (ASA) I-IV, any upper respiratory tract infections in the last two weeks, current or previous respiratory risk factors, and any signs of obstructive sleep apnoea, details of know abnormal pulse oximetry, risk factors for postoperative nausea and vomiting and any history of prematurity. Details of their anaesthetic management and their time spend in the post-anaesthetic care unit (PACU) will also be recorded, as well as any incidence of respiratory adverse events at any time from induction of anaesthesia until discharge from PACU. Incidence of sore throat or hoarse voice will be collected on the day of surgery 2-4 hours post PACU discharge.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Participant Inclusion Criteria
Exclusion criteria
Patient will have direct removal of ETT and transferred to PACU breathing independently or with a face mask.
Patient will have LMA inserted following deep extubation of endotracheal tube.
Time frame: Assessed by the anaesthetist along the course of the patient's perioperative pathway from extubation until their discharge from the post-anaesthetic care unit (PACU)
Perioperative respiratory adverse events (PRAE) are defined as:
Major PRAE: laryngospasm or bronchospasm, as determined by the anaesthetist, or desaturation <85% SpO2 for more than 1 minute on pulse oximetry.
Minor PRAE: desaturation (<85% SpO2 for more than 10 secs on pulse oximetry), airway obstruction, severe coughing, post-operative stridor.
Time frame: Assessed by the anaesthetist along the course of the patient's perioperative pathway from extubation until their discharge from the post-anaesthetic care unit (PACU)
Perioperative respiratory adverse events (PRAE) are defined as:
Major PRAE: laryngospasm or bronchospasm, as determined by the anaesthetist, or desaturation <85% SpO2 for more than 1 minute on pulse oximetry.
Minor PRAE: desaturation (<95% SpO2 for more than 10 seconds on pulse oximetry), airway obstruction, severe coughing, post-operative stridor.
Each individual PRAE (laryngospasm, bronchospasm, desaturation, airway obstruction, severe persistent coughing and post-operative stridor) will be considered separately.
Time frame: Any airway interventions given along the course of the patient's perioperative pathway from extubation until their discharge from the post-anaesthetic care unit (PACU) will be recorded
Airway interventions are defined as: requirement for jaw thrust after airway removal, CPAP, supplemental O2 for over 10 min after the airway has been removed awake, need to reinsert LMA or ETT, use of airway adjuncts (e.g. guedel once airway removed), need for propofol or muscle relaxant following airway removal.
Time frame: A single measurement of using the PAED score will be taken 10 minutes after the patient is assessed to first be at a UMSS of 2 as per the PACU nurse.
PAED scale ranges from 0 to 20, a score of 0 is equivalent to no delirium and 20 is significant delirium
Time frame: Assessments of pain will be taken at 5 and 20 minutes after the patient is assessed to first be at a UMSS of 2 as per the PACU nurse.
Pain will be assessed by the PACU nurse by asking the patient to rate their pain on a scale of 0 to 10, where 0 is no pain and 10 is worst possible pain.
Time frame: All opioid analgesia usage from PACU admission until discharge will be recorded.
Looking at the number of additional opioid analgesia patients need in each group and comparing these.
Time frame: Time at which patient arrives in PACU and time at which their UMSS score is ≤2 will be measured by the PACU nurse during their post-operative PACU admission. Measured in minutes/hours on day of surgery for each patient.
End of surgery is defined as completed application of dressing/cast (as applicable). This will be minutes to hours of time.
Time frame: PACU time is defined as the time from arrival in PACU until ready for discharge from PACU.
Time frame: Assessed from the time at which the patient is admitted to PACU until the time that they are discharged.
Rates of vomiting will be as reported by the PACU nurse. Self-reported nausea will be recorded only in children over the age of 6 years.
Time frame: Collected on the day of surgery, 2-4 hours post discharge from PACU.
Sore throat score as rated on a 4-point scale - nil, mild, moderate, severe. Hoarse voice as identified by parent and rated on a 4-point scale nil, mild, moderate, severe.
Contact information is provided by the study sponsor or research team.
Britta S. von Ungern-Sternberg, MD PHD
CONTACT
Lliana B Slevin, BSc
CONTACT
Telethon Kids Institute
Other
Acronym: BELUGA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05489809
Endotracheal Extubation
Karachi, Sindh, Pakistan
View Trial DetailsNCT02590757
Endotracheal Extubation, Female Urogenital Diseases and Pregnancy Complications
Seoul, South Korea
View Trial DetailsNCT03689309
Endotracheal Extubation, Mechanical Ventilation
Orléans, France
View Trial DetailsNCT01765530
Airway Control, Airway Obstruction
Boston, Massachusetts, United States
View Trial Details